Results from early stage trials of Johnson & Johnson’s COVID-19 vaccine are promising, showing the one-dose vaccine generates an immune response in nearly all volunteers, with minimal side effects.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback